Underactive Pituitary Gland in Dogs (Hypopituitarism)

  • Occurrence: very rare
  • Location of disease: Head/Neck
Author: Dr. med. vet. Gisa Löwe | Last modified: 03.08.2026
Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Hypopituitarism in dogs is a rare endocrine disorder characterized by insufficient production of one or more hormones by the pituitary gland, also known as the hypophysis.

Das Wichtigste auf einen Blick

Hypopituitarism in dogs is a condition in which the pituitary gland, a small gland in the brain, functions insufficiently and therefore does not produce important hormones in adequate amounts. These hormones are crucial for growth, metabolism, and other bodily functions. Causes can be primary in the pituitary gland itself or secondary in other brain regions. Common primary causes are developmental disorders such as genetically determined dwarfism, especially in German Shepherds, as well as tumors, which can be benign or malignant. Symptoms include delayed development, dwarfism, hair loss, as well as skin changes and vision changes. Diagnosis requires comprehensive clinical examinations, hormone measurements, and possibly imaging procedures such as MRI or CT to detect structural anomalies or tumors. Treatment depends on the cause and may include hormone therapies, surgical procedures, or radiation therapy. Regular veterinary monitoring is important to adjust therapy and improve quality of life. The prognosis varies depending on the cause: genetic disorders can improve quality of life but may affect life expectancy, while the prognosis for tumors depends on their type and location. Prevention is difficult, but responsible breeding practices and regular veterinary examinations can help minimize risks and enable early detection.

Ursachen

The pituitary gland is a small, pea-sized gland at the base of the brain that plays a central role in the endocrine system. It produces and regulates various hormones that are crucial for growth, metabolism, and other important bodily functions. These hormones include growth hormone (GH), adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH), and luteinizing hormone (LH).

Pituitary gland underactivity can develop both as a primary and secondary condition. Primary causes lie within the pituitary gland itself, while secondary causes are found in the hypothalamic region or other parts of the brain that influence the pituitary gland. The most common primary causes are developmental disorders or tumors. One of the most well-known developmental disorders is dwarfism, which is caused by a genetic anomaly and commonly occurs in German Shepherds.

Another common cause of hypopituitarism in dogs is tumors, which can be either benign or malignant. These tumors can directly affect the pituitary gland or disrupt the hormonal balance by producing hormone-like substances. Radiation therapy or surgical procedures in the brain can also impair pituitary gland function and lead to underactivity. In rare cases, inflammation of the pituitary gland, known as hypophysitis, can also be the cause.

Symptoms

Rare symptoms:

The symptoms of hypopituitarism in dogs are varied and depend on the specific hormones affected. General signs may include growth disorders such as dwarfism and delayed development. In adult dogs, muscle mass loss and general weakness may occur. Typically, the puppy coat—a soft, woolly coat—is retained.

Other specific symptoms include reduced stress resistance, as ACTH is lacking and cortisol production decreases. Dogs may also show reduced thyroid function if TSH is affected, leading to symptoms such as weight gain, lethargy, and hair loss. Insufficient production of LH and FSH can lead to cycle disorders in female dogs and fertility problems in male dogs.

In cases where pituitary underactivity is caused by inflammation or a tumor, neurological symptoms such as behavioral changes, convulsions, or balance problems may occur.

Diagnose

Diagnosis of hypopituitarism in dogs requires a careful clinical examination as well as specific hormone tests. The veterinarian will typically conduct a detailed medical history to inquire about the symptoms and their onset. Blood tests are crucial to measure the levels of various pituitary hormones and rule out other possible causes of the symptoms.

An ACTH stimulation test can be used to assess adrenal cortex function and confirm ACTH deficiency. Another test, the TRH stimulation test, can be used to check thyroid function. Imaging procedures such as MRI or CT are helpful in identifying structural anomalies or tumors in the pituitary region.

In some cases, a biopsy may be necessary, especially if a tumor is suspected. The biopsy helps determine the type of tumor and develop an appropriate treatment strategy.

Therapie

Treatment of hypopituitarism in dogs depends on the underlying cause and the affected hormones. For hormonal deficits, therapy typically involves administering hormone preparations to replace the missing hormones. This includes glucocorticoids to support adrenal cortex function, thyroid hormones to treat hypothyroidism, and growth hormones if necessary.

If a tumor is the cause, surgical removal may be required if possible. In some cases, radiation therapy or chemotherapy may be used to treat tumors. Inflammatory conditions of the pituitary gland may require immunosuppressive therapy.

Regular veterinary check-ups are crucial to monitor the effectiveness of the treatment and adjust dosages if necessary. Close collaboration with the veterinarian is also important to improve the quality of life of the affected dog.

Prognose und Nachsorge

The prognosis for dogs with hypopituitarism varies greatly and depends on the underlying cause. For genetic disorders such as pituitary dwarfism, quality of life can be improved through appropriate hormone treatment, although life expectancy may be somewhat limited.

For tumors, the prognosis depends on the type, size, and location of the tumor. Benign tumors can often be successfully treated, while malignant tumors have a poorer prognosis. Early diagnosis and treatment are crucial for a better prognosis.

Overall, the long-term prognosis for dogs with hypopituitarism is generally better if the condition is detected and treated early. Regular monitoring and adjustment of treatment to the individual needs of the dog are crucial for treatment success.

Prävention

Since many causes of hypopituitarism are genetic or tumor-based, prevention is often difficult. In breeds prone to genetically determined forms of hypopituitarism, responsible breeding can help reduce the spread of the disease. This includes testing breeding animals for genetic markers associated with the disease.

Early detection and treatment of conditions that can lead to pituitary underactivity is also important. Regular veterinary examinations and careful observation of the dog’s health status can help detect signs of pituitary underactivity early. A proactive approach to health care can help minimize the risk of complications and maintain quality of life.

By ensuring a balanced diet and adequate exercise, dog owners can also contribute to their dog’s overall health and potentially strengthen resistance to certain diseases. Regular vaccinations and preventive examinations are also important aspects of preventing diseases that can indirectly lead to pituitary underactivity.

Ausblick auf aktuelle Forschung

Hypopituitarism is an underactive pituitary gland, the gland that controls many other hormone systems. In veterinary medicine, the congenital form in dogs is primarily important, often visible as pituitary dwarfism with growth disorders, coat changes, and other hormone deficiencies. The German Shepherd is considered the classic predisposed breed; genetic developmental disorders of the pituitary gland have also been described in other breeds. (merckvetmanual.com, pubmed.ncbi.nlm.nih.gov)

The most important research outlook currently lies in better clarification of causes. Today, it is known that genetic defects in pituitary development are involved in some dogs; as a result, the disease is increasingly understood as a disorder of organ development and not just as a “growth problem.” At the same time, diagnostics are improving through the combination of hormone profiles, imaging, and genetic tests. (pubmed.ncbi.nlm.nih.gov, frontiersin.org)

A second research focus is therapy. Since multiple hormones are usually lacking, the future is less about a single solution and more about individualized hormone replacement concepts and better long-term monitoring. It is still particularly unclear how early intervention must occur to permanently improve growth, skin, metabolism, and quality of life. (merckvetmanual.com, frontiersin.org)

Overall, the outlook is good: research is shifting from pure symptom treatment toward earlier diagnosis, genetic classification, and more targeted management.

Frequently Asked Questions (FAQs)

1. What is hypopituitarism?
Hypopituitarism is an underactive pituitary gland (hypophysis) that leads to a deficiency of pituitary hormones. Since the pituitary gland controls the function of other hormone glands such as the thyroid, adrenal cortex, and gonads, various secondary failures occur. In dogs, congenital growth hormone deficiency with dwarfism plays a particularly important role.
2. Which breeds are particularly affected?
The German Shepherd is classically affected, in which pituitary dwarfism is inherited in an autosomal recessive manner. Saarloos Wolfdog, Czechoslovakian Wolfdog, and occasionally Karelian Bear Dogs also show the disease. The underlying mutation affects the LHX3 gene.
3. What symptoms does a puppy with dwarfism show?
The puppies appear unremarkable in the first two to three months, but then fall significantly behind their littermates in growth. Typical features are a puppy-like, soft coat, absence of guard hair, bilateral symmetrical alopecia, delayed tooth change, and a proportionally small but well-formed body structure. Later, skin changes and hyperpigmentation appear.
4. What other organ systems are affected?
In addition to growth hormone deficiency, there is usually also a secondary deficiency of thyroid hormone and often gonadotropins. This results in intolerance to cold, slowed metabolism, infertility, and failure to reach sexual maturity. Adrenal cortex function usually remains intact but should be checked.
5. How is the diagnosis made?
Clinical presentation, X-ray findings with delayed closure of growth plates, and a low IGF-1 level in the blood are indicative. The diagnosis is confirmed by a stimulation test with GHRH or clonidine and increasingly by genetic testing for the LHX3 mutation in German Shepherds.
6. How is hypopituitarism treated?
Substitution of growth hormone from cattle or pigs is rarely used due to antibody formation and costs. More commonly, progestin (for example, medroxyprogesterone acetate) is administered, which indirectly stimulates GH secretion from the mammary gland. An existing thyroid hormone deficiency is compensated with levothyroxine.
7. What is the life expectancy?
Untreated, life expectancy is usually only three to five years. Causes of death are often progressive renal failure, severe skin changes, or neurological symptoms. With consistent hormone substitution, life expectancy can be extended but usually remains below the breed average.
8. Is hypopituitarism painful?
The disease itself is not painful. Limitations arise from cold sensitivity, skin infections, itching, and progressive renal insufficiency. Good skin care and a warm environment significantly improve quality of life.
9. Can affected dogs be used for breeding?
Affected animals are infertile and do not belong in breeding anyway. It is important to identify carriers through genetic testing. Mating two carriers must be strictly avoided. German Shepherd breeding associations increasingly require an LHX3 test before breeding approval.
10. How is hypopituitarism distinguished from other growth disorders?
Important differential diagnoses are congenital hypothyroidism, portosystemic shunts, severe intestinal diseases, and chondrodysplastic growth disorders. Proportional dwarfism with a puppy-like coat and normal body structure is typical of hypopituitarism, while chondrodysplasias lead to shortened limbs with a normal trunk.

Literatur

  • Greco, D. S. (2012). Pituitary deficiencies. Top Companion Animal Medicine, 27(1), 2–7. https://doi.org/10.1053/j.tcam.2012.04.002
  • Hamann, F., Kooistra, H. S., Mol, J. A., Gottschalk, S., Bartels, T., & Rijnberk, A. (1999). Pituitary function and morphology in two German shepherd dogs with congenital dwarfism. Veterinary Record, 144(23), 644–646. https://doi.org/10.1136/vr.144.23.644
  • Kooistra, H. S., Voorhout, G., Mol, J. A., & Rijnberk, A. (2000). Combined pituitary hormone deficiency in German shepherd dogs with dwarfism. Domestic Animal Endocrinology, 19(3), 177–190. https://doi.org/10.1016/S0739-7240(00)00074-6
  • Voorbij, A. M. W. Y., van Steenbeek, F. G., Vos-Loohuis, M., Martens, E. E. C. P., Hanson-Nilsson, J. M., van Oost, N. J. M., van Oost, B. A., Leegwater, P. A. J., & Kooistra, H. S. (2011). A contracted DNA repeat in LHX3 intron 5 is associated with aberrant splicing and pituitary dwarfism in German shepherd dogs. PLoS ONE, 6(11), e27940. https://doi.org/10.1371/journal.pone.0027940
  • Voorbij, A. M. W. Y., Leegwater, P. A. J., & Kooistra, H. S. (2014). Pituitary dwarfism in Saarloos and Czechoslovakian wolfdogs is associated with a mutation in LHX3. Journal of Veterinary Internal Medicine, 28(6), 1770–1774. https://doi.org/10.1111/jvim.12448
  • Voorbij, A. M. W. Y., Meij, B. P., van Bruggen, L. W. L., Grinwis, G. C. M., Stassen, Q. E. M., & Kooistra, H. S. (2015). Atlanto-axial malformation and instability in dogs with pituitary dwarfism due to an LHX3 mutation. Journal of Veterinary Internal Medicine, 29(1), 207–213. https://doi.org/10.1111/jvim.12523
  • Kyöstilä, K., Niskanen, J. E., Arumilli, M., Donner, J., Hytönen, M. K., & Lohi, H. (2021). Intronic variant in POU1F1 associated with canine pituitary dwarfism. Human Genetics, 140(11), 1553–1562. https://doi.org/10.1007/s00439-021-02259-2
  • Thaiwong, T., Corner, S., La Forge, S., Forge, S., & Kiupel, M. (2021). Dwarfism in Tibetan Terrier dogs with an LHX3 mutation. Journal of Veterinary Diagnostic Investigation, 33(4), 740–743. https://doi.org/10.1177/10406387211007526
  • Kitzmann, S., Hartmann, K., Zablotski, Y., Rieger, A., Mueller, R. S., & Wehner, A. (2021). Wellbeing, quality of life, presence of concurrent diseases, and survival times in untreated and treated German Shepherd dogs with dwarfism. PLoS ONE, 16(8), e0255678. https://doi.org/10.1371/journal.pone.0255678
  • Schils, G., Stammeleer, L., & Daminet, S. (2025). Pituitary dwarfism and adrenocorticotropic hormone deficiency in a White Swiss Shepherd dog with LHX3 mutation. Journal of Veterinary Internal Medicine, 39(5), e70193. https://doi.org/10.1111/jvim.70193